Henderson Biotech Innovation Master Fund Ltd Janus serves as Executive at ARCA biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Henderson Biotech Innovation Master Fund Ltd Janus has executed 11 insider transactions totaling $1.4M, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 16, 2024 involved purchasing 428 shares valued at $1.3K.
Henderson Biotech Innovation Master Fund Ltd Janus currently holds 2,117,213 shares of ARCA biopharma, Inc. (ABIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Henderson Biotech Innovation Master Fund Ltd Janus has been a net buyer of ABIO stock. They have purchased $1.4M and sold $0 worth of shares.
Henderson Biotech Innovation Master Fund Ltd Janus's most recent insider trade was on Aug 16, 2024, when they purchased 428 shares at $2.98 per share.
Get notified when new Form 4 filings are submitted
| $2.93 |
| Discretionary |
| Jul 11, 2024 | ABIO | $326.2K | Purchase | 94,537 | $3.45 | Discretionary |
| Jul 10, 2024 | ABIO | $115.9K | Purchase | 33,500 | $3.46 | Discretionary |
| Jul 10, 2024 | ABIO | $76.0K | Purchase | 21,963 | $3.46 | Discretionary |
| Jul 9, 2024 | ABIO | $58.0K | Purchase | 16,917 | $3.43 | Discretionary |
| Jul 8, 2024 | ABIO | $62.3K | Purchase | 17,600 | $3.54 | Discretionary |
| Jul 8, 2024 | ABIO | $101.9K | Purchase | 29,892 | $3.41 | Discretionary |
| Jul 5, 2024 | ABIO | $17.1K | Purchase | 5,000 | $3.41 | Discretionary |
| Jul 5, 2024 | ABIO | $80.0K | Purchase | 23,326 | $3.43 | Discretionary |
| Jul 3, 2024 | ABIO | $589.4K | Purchase | 166,042 | $3.55 | Discretionary |